Table 2. Postnatal maternal effects of meQTL.
meQTL | 2.1 | 2.2 | 7.1 | 11.1 | 17.1 | 19.1 | R2 | |
---|---|---|---|---|---|---|---|---|
cM | 37.5 | 53.8 | 57.0 | 52.0 | 15.8 | 49.7 | ||
Mb | 62.6 | 112.1 | 122.7 | 90.6 | 32.8 | 53.8 | ||
C.I. (Mb) | 39.6–75.9 | 82.2–118.0 | 117.6–134.5 | 84.8–96.6 | 28.5–46.6 | 47.3–58.6 | ||
Traits | Early | +aNa | +dN | –aN | +aN | |||
Mid | +aN | +dN | +dN | –aN | +aN–dN | |||
Late | –aN | +aN–dN | ||||||
Week 1 | +aN | +dNa | –aN | –aN | 12.6 | |||
Week 2 | +aN | +dN | +dN | –aN | –dN | 12.9 | ||
Weaning | Week 3 | +aN+dN | +dN | –aN | +aN | 16.2 | ||
Week 4 | +aN | +dN | +dN | –aN | +aN–dN | 16.6 | ||
Week 5 | +aN | +dN | +dN | –aN | +aN–dN | 12.7 | ||
Week 6 | +aN | +dN | –aN | +aN–dN | 10.6 | |||
Week 7 | +aN | –aN | +aN–dN | 8.8 | ||||
Week 8 | +aN | –aN | +aN–dN | 8.7 | ||||
Week 9 | +aN | +dN | –aN | –dN | 8.3 | |||
Week 10 | +aN | +dN | –aN | –dN | 7.6 | |||
Grow 1–2 | –dN | 3.6 | ||||||
Grow 2–3 | +aN+dN | +dN | +aN | 11.9 | ||||
Grow 1–3 | +aN | +aN–dN | 10.0 |
For each of the five meQTL that map to the nurse genotypes (indicating postnatal effects) we present the map position [in centimorgans (cM) and in megabases (Mb)] with the confidence interval (in Mb) and the temporal pattern of effect. Early, mid, and late indicate the significance of the multivariate test. The effects on each of the weekly weight measurements and the three preweaning growth phases are given by the type (additive, aN, or dominance, dN) and sign of effect (i.e., positive or negative). Entries in boldface type are significant using the chromosome-level significance test. Numerical values of all effects and significance tests are given in Table S4. The proportions of variance accounted for by the set of QTL (R2) for each trait are also included.
Significant using the genome-wide threshold.